Literature DB >> 19963103

Symptoms of chronic solvent encephalopathy: Euroquest questionnaire study.

Ari Kaukiainen1, Hanna Kaisa Hyvärinen, Ritva Akila, Markku Sainio.   

Abstract

The aim was to study the symptomatology of chronic solvent encephalopathy (CSE), and the persistence of the symptoms. We examined how Euroquest, a neurotoxic symptom questionnaire, distinguished workers with verified CSE from unexposed employees, and evaluated symptom cut-off for CSE. Another aim was to study the effect of age on the responses. CSE cases confirmed at the Finnish Institute of Occupational Health had completed Euroquest either before their first investigation procedure (CSE-1 group, n=33), or before attending a routine control for previously diagnosed CSE (CSE-2, n=43). Non-exposed carpenters served as referents (n=292). We studied responses to single questions and to symptom domains. The domain with the highest AUC (area under the ROC: Receiver Operating Characteristic Curve) value was chosen to study cut-off points. CSE groups reported nearly all 59 symptoms more frequently than the carpenters. There was only little difference between younger and older carpenters. CSE-1 reported 12 symptoms more often than CSE-2, but no significant differences were found in the memory and concentration domain, which had the highest AUC, above 0.9. Using a three out of 10 symptoms cut-off point, 97% of the CSE-1 cases and 80% of the carpenters were classified correctly. At a four-symptom cut-off, the sensitivity was 93% and specificity 87%. The memory and concentration as core symptoms distinguished CSE cases from unexposed workers and remain, even after cessation of exposure. The effect of age on Euroquest was minor. Euroquest is recommended for the screening of CSE in solvent-exposed work-force and in the diagnostic process of CSE. We propose three memory and concentration symptoms as cut-off to minimize under-detection.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19963103     DOI: 10.1016/j.neuro.2009.03.010

Source DB:  PubMed          Journal:  Neurotoxicology        ISSN: 0161-813X            Impact factor:   4.294


  7 in total

1.  Reconsideration of the WHO NCTB strategy and test selection.

Authors:  W Kent Anger
Journal:  Neurotoxicology       Date:  2014-08-27       Impact factor: 4.294

2.  Neuropsychological performance in solvent-exposed vehicle collision repair workers in New Zealand.

Authors:  Samuel Keer; Bill Glass; Dave McLean; Elizabeth Harding; Duncan Babbage; Janet Leathem; Yanis Brinkmann; Bradley Prezant; Neil Pearce; Jeroen Douwes
Journal:  PLoS One       Date:  2017-12-13       Impact factor: 3.240

3.  BRain health and healthy AgeINg in retired rugby union players, the BRAIN Study: study protocol for an observational study in the UK.

Authors:  Valentina Gallo; Damien McElvenny; Catherine Hobbs; Donna Davoren; Huw Morris; Sebastian Crutch; Henrik Zetterberg; Nick C Fox; Simon Kemp; Matthew Cross; Nigel K Arden; Madeleine A M Davies; Andrea Malaspina; Neil Pearce
Journal:  BMJ Open       Date:  2017-12-26       Impact factor: 2.692

Review 4.  Neuropsychological symptoms in workers handling cargo from shipping containers and export logs.

Authors:  Ruth Hinz; Andrea 't Mannetje; Bill Glass; Dave McLean; Jeroen Douwes
Journal:  Int Arch Occup Environ Health       Date:  2022-05-06       Impact factor: 2.851

5.  Occurrence of cognitive and neurological symptoms in norwegian dentists.

Authors:  Bjørn Hilt; Kristin Svendsen; Tore Syversen; Oddfrid Aas; Torgunn Qvenild
Journal:  Saf Health Work       Date:  2011-06-30

6.  Symptoms of Neurotoxicity among Carpenters Living in Rural Ecuador: A Population-based Study (The Atahualpa Project).

Authors:  Oscar H Del Brutto; Robertino M Mera; Ani Reich de Amador; Mauricio Zambrano; Pablo R Castillo
Journal:  J Neurosci Rural Pract       Date:  2017 Oct-Dec

7.  Carpal Tunnel Syndrome Among Male French Farmers and Agricultural Workers: Is It Only Associated With Physical Exposure?

Authors:  Yves Roquelaure; Sylvaine Jégo; Béatrice Geoffroy-Perez; Emilie Chazelle; Alexis Descatha; Bradley Evanoff; Ronan Garlantézec; Julie Bodin
Journal:  Saf Health Work       Date:  2019-12-17
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.